Aardvark Therapeutics Appoints Renowned Biopharma Leaders Roy D. Baynes and Susan E. Graf to its Board of Directors
Aardvark Therapeutics, Inc. (Aardvark), a clinical-stage biopharmaceutical company focused on developing novel, ...
Hosted on MSN49m
Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug
Viking Therapeutics VKTX announced that it has started the phase II VENTURE-Oral Dosing study to evaluate the safety and ...
Bonnaroo 2025 to debut Infinity Stage: What 3D, immersive experience might look like
The 3D, immersive sound, open-air concert experience developed by Polygon Productions, is set to make its U.S. debut at ...
Things to do in Dallas County this weekend include tea parties, soup fundraiser
Learn about the state's prohibition journey or about tea parties past and present, enjoy soup and baked goods and more this ...
Pharmabiz48m
ModeX Therapeutics announces Epstein-Barr virus vaccine candidate enters phase I study in collaboration with Merck
ModeX Therapeutics Inc., an OPKO Health company, announces dosing of the first participant in the phase I study (NCT06655324) of an Epstein-Barr virus (EBV) vaccine candidate being developed in ...